Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2010-11-02 Earnings Release
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 2, 2010, reporting the company's financial results for the third quarter ended September 30, 2010. It mentions a press release and a conference call regarding these results. The document itself is a current report filing (Form 8-K) that includes a press release as an exhibit but does not contain detailed financial statements or comprehensive financial analysis. The length is 2795 characters, which is relatively short and consistent with a regulatory announcement rather than a full financial report. The document is primarily an announcement of quarterly financial results and a conference call, which aligns with the definition of an Earnings Release (ER). Therefore, the appropriate classification is Earnings Release (ER).
2010-11-02 English
4 Filing
Director's Dealing
2010-10-29 English
SC 13G/A Filing
Major Shareholding Notification
2010-10-05 English
SC 13D Filing
Major Shareholding Notification
2010-09-27 English
8-K Filing
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement related to amendments to the company's credit facility and loan agreements. It details financing arrangements, covenants, and terms of the loan agreements. There is no presentation of financial statements or comprehensive financial performance data, nor is it an earnings release or annual/interim report. The focus is on financing activity and capital structure changes. Therefore, this filing fits the category of Capital/Financing Update (CAP). The document length is over 6,000 characters and contains substantive detail about the financing agreements, not just an announcement of a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2010-09-17 English
SC 13D Filing
Major Shareholding Notification
2010-09-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.